Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
ByHeart Formula Recall Lawsuit Parents are now filing ByHeart recall lawsuits alleging that contaminated infant formula caused botulism and other serious illnesses after the company failed to prevent or warn about dangerous manufacturing lapses.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Homeopathic Teething Tablets, Gels, Risk To Babies, FDA Warns October 3, 2016 Martha Garcia Add Your Comments Federal health experts are warning parents not to use homeopathic teething tablets or gels, due to the risk of serious problems they may pose for babies. An FDA safety alert was issued September 30, indicating that homeopathic teething tablets and gels commonly used to ease pain among infants have been linked to reports of seizures and other serious side effects, which the agency is currently analyzing. Homeopathic teething tablets and gels are marketed as natural products, and sold over-the-counter at retail stores to help relieve teething symptoms in children. The tablets are placed on a baby’s tongue to dissolve, and the homeopathic products are often a favorite among parents who want to offer their child pain relief without turning to traditional drugs and medication. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA indicates that reports of problems with the teething tablets and gels suggest that there may be serious risks associated with the use. The agency is testing product samples to investigate further. While this latest warning does not mention a specific problem or incident, in 2010, problems with Hyland’s Teething Tablets resulted in a recall, after the agency discovered that that the tablets contained varying amounts of belladonna, a potentially harmful ingredient. Belladonna is a plant with leaves and berries that can be toxic if consumed in large amounts, thus the amounts used in homeopathic products must be carefully controlled. At that time, the FDA received reports children were taking more tablets than recommended because the product didn’t have childproof caps. An analysis also concluded the levels of belladonna in the Hyland’s products were inconsistent, posing a threat to children. Directions on the package indicate children can take two to three tablets up to four times a day. This latest safety alert indicates that the homeopathic teething tablets and gels have not been evaluated or approved by the FDA for safety or efficacy. The FDA is also not aware of any “proven health benefit” offered by homeopathic teething products. The agency recommends consumers stop using the products immediately and dispose of any remaining tablets or gels. Parents should seek medical care if a child experiences seizures, difficulty breathing, lethargy, excessive sleepiness, muscle weakness, skin flushing, constipation, difficulty urinating or agitation after using the homeopathic teething tablets or gels. The FDA said it will continue to keep the public updated concerning the situation as more information has become available, but did not detail any reports of incidents involving the products. “Teething can be managed without prescription or over-the-counter remedies,” said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. “We recommend parents and caregivers not give homeopathic teething tablets and gels to children and seek advice from their health care professional for safe alternatives.” In 2012, other baby teething products came under fire after federal health regulators warned of a risk Baby Orajel, Anbesol, Hurricane and other over-the-counter tooth pain gel products posed to children. That warning was directed at a non-homeopathic product used to relieve pain from teething and toothache. The warning indicated benzocaine, the main ingredient, may cause children to develop a rare condition causing brain damage or death. Parents and caregivers are warned to report adverse events from any product to the FDA’s Med Watch Program at 800-332-1088. Written by: Martha Garcia Health & Medical Research Writer Martha Garcia is a health and medical research writer at AboutLawsuits.com with over 15 years of experience covering peer-reviewed studies and emerging public health risks. She previously led content strategy at The Blogsmith and contributes original reporting on drug safety, medical research, and health trends impacting consumers. Tags: Childrens Drugs, Dietary Supplement, Hylands Teething Tablet Recall, Teething Relief, Teething Tablet More Lawsuit Stories Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians December 9, 2025 LINX Device Recall Lawsuit Filed Over Risk of Bead Separation Complications December 9, 2025 Gabapentin Side Effects May Mimic Heart Failure Symptoms: Study December 9, 2025 2 Comments dar October 4, 2016 But we all know Homeopathy is a 300 yr old sham/placebo…The FDA has been trumpeting this for decades…so Why the volte-face ? Michelle October 3, 2016 As I suspected, this statement by the FDA has little basis in what is actually going on. Warned about a possible recall by my fiance, I checked the web, reading the warning and checking the Hyland’s website. There were no posted recalls. What I believe is important is the swiftness Hyland’s acted with under the last recall they had with their teething tablets…this indicates they truly are at least partially worried about the safety of their littlest consumers. Granted, in business, there’s always the bottom line, and I’m sure that played a hefty role – but my point is, they weren’t *obviously* forced to recall their prodect when shown possible dangers. I believe this is a tactic by the FDA to further reduce parental autonomy in choosing how to treat our children. Look at the overwhelming fear of fevers parents have nowadays. Yes, fevers can be dangerous in certain conditions. Most often they are exactly what the body needs to kill a bacteria or virus and we should allow them to run their course as long as they remain within the safety guidelines or within the parental comfort zone, whichever is stricter. Get homeopathic rememdies off the shelves, make parents too afraid to use anything but pharmeceutical products, and have them running to their kid’s ped for every sniffle. Sounds like a lot of money changing hands rather than the best interests of people. Please see this counter-statement made by Hyland’s before tossing your money in the trash (obviously, use good sense – if you have a gut feeling or there’s evidence of side effects, toss ’em!): http://www.hylands.com/media/news/hylands-response-fda-advisory-regarding-homeopathic-teething-tablets-and-gels Parents, especially, DO YOUR OWN RESEARCH. Relying upon any government agency to put people before money is foolish at best. That’s like trusting a politician to tell the truth – if their mouth is moving, the safest bet is they’re lying. Same here – if the government is telling you something, do research and check both for and against, then make up your own mind. This also applies to any other “expert” – including homeopathic, naturopathic, holistic, pediatrician, pcp, etc. Step away from the fear and allow knowledge to empower you. NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: today) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025) Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: yesterday) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025) Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 4 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)
Class Action Lawsuit Against FanDuel Seeks To Recover Losses for Californians (Posted: today) A lawsuit against FanDuel claims the company is operating illegal fantasy sports betting in California, which has an active ban against online gambling. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITLawsuit Over DraftKings ‘No Risk’ Bet Promotions Cleared to Move Forward (11/25/2025)Lawsuit Over FanDuel, DraftKings Sports Betting Problems Returned to State Court (11/20/2025)Sports Betting Corruption and Addiction Concerns Highlighted By Recent MLB, NBA Player Indictments (11/12/2025)
Court To Weigh Evidence That Depo-Provera Causes Meningioma Tumors in Mid-2026 (Posted: yesterday) A federal judge is expected to decide which scientific experts each side may present during the early Depo-Provera meningioma test trials around the middle of next year. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit MDL Status Hearings Scheduled Throughout 2026 (12/01/2025)Depo-Provera Litigation Now Includes Over 2,000 Brain Tumor Lawsuits Brought by Women (11/20/2025)Lawsuit Alleges Depo-Provera Caused Brain Surgery, After Meningioma Diagnosis (11/11/2025)
Dupixent CTCL Lawsuit Filed Over Diagnosis of Both Mycosis Fungoides and Sezary Syndrome (Posted: 4 days ago) A Louisiana man was diagnosed with two rare forms of T-cell lymphoma after receiving Dupixent injections for less than two years. MORE ABOUT: DUPIXENT LAWSUITDrug Makers Must Respond to Dupixent Lawsuit Over Lymphoma Diagnosis by Jan. 7, 2026 (12/02/2025)Dupixent for Nasal Polyps Nears FDA Approval Amid Lymphoma Side Effect Lawsuits (11/17/2025)Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (10/29/2025)